The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 134, Issue 10, Pages 2314-2321
Publisher
Wiley
Online
2013-10-31
DOI
10.1002/ijc.28571
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer
- (2013) A Atmaca et al. BRITISH JOURNAL OF CANCER
- Prognostic and predictive value of estrogen receptor 1 expression in completely resected non-small cell lung cancer
- (2013) Wolfgang Michael Brueckl et al. INTERNATIONAL JOURNAL OF CANCER
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Estrogen receptors, antiestrogens, and non-small cell lung cancer
- (2011) T. A. Bogush et al. BIOCHEMISTRY-MOSCOW
- Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer
- (2010) M Ihnen et al. BRITISH JOURNAL OF CANCER
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunohistochemical Expression of Estrogen Receptor in Adenocarcinomas of the Lung
- (2010) Carmen Gomez-Fernandez et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- RNA Extraction from Archival Formalin-Fixed Paraffin-Embedded Tissue: A Comparison of Manual, Semiautomated, and Fully Automated Purification Methods
- (2009) K. Bohmann et al. CLINICAL CHEMISTRY
- Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue
- (2009) Silvia Darb-Esfahani et al. ENDOCRINE-RELATED CANCER
- Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies
- (2009) Claudio Zamagni et al. ENDOCRINE-RELATED CANCER
- Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial
- (2009) Rowan T Chlebowski et al. LANCET
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial
- (2008) George Pentheroudakis et al. BREAST CANCER RESEARCH AND TREATMENT
- Bone metastasis is strongly associated with estrogen receptor–positive/progesterone receptor–negative breast carcinomas
- (2008) Bing Wei et al. HUMAN PATHOLOGY
- Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer
- (2008) Anne M. Traynor et al. LUNG CANCER
- Oestrogen receptor β over expression in males with non-small cell lung cancer is associated with better survival
- (2007) Birgit Guldhammer Skov et al. LUNG CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now